Donate to AGSD

Thank you for your support!

Become a Member

Access to scholarships, events, and more!

THE BEAM-301 CLINICAL STUDY

A phase 1/2, multicenter, open-label, single-ascending dose study to evaluate the safety
and efficacy profiles of BEAM-301 in adult patients who have GSD1a and have the G6PC
c.247C>T (R83C) variant(s)